Listen to “BLADDER CANCER IS THE SIXTH MOST COMMON CANCER IN THIS COUNTRY?” on Spreaker.
DID YOU KNOW THAT BLADDER CANCER IS THE SIXTH MOST COMMON CANCER IN THIS COUNTRY? MOST BLADDER CANCER DIAGNOSES – ABOUT 75% – ARE N-M-I-B-C, WHICH STANDS FOR. NON-MUSCLE INVASIVE BLADDER CANCER.
NOT EVERYONE RESPONDS TO THE STANDARD TYPE OF TREATMENT FOR NMIBC, WHICH MAY LEAD DOCTORS TO RECOMMEND SURGERY TO REMOVE THE BLADDER.
A DIFFERENT TREATMENT APPROACH MAY OFFER PEOPLE WITH THIS TYPE OF BLADDER CANCER MORE TIME BEFORE HAVING TO CONSIDER THIS RADICAL TYPE OF SURGERY…
DR. LARRY KARSH (CAR-SH), ALONG WITH PATIENT MIKE, JOIN US NOW WITH MORE.
BIO:
Dr. Karsh earned his MD from The Chicago Medical School. He completed his General Surgical training at The University of Colorado Health Sciences Center and his Urology Residency at the Brigham and Women’s Hospital/Harvard Medical School.
Dr. Karsh was a co-founder of The Urology Center of Colorado which was recently acquired by Advent Health Urology Denver where he serves as an attending Urologist and Director of Research. He is a certified principal investigator with an experience of more than 275 clinical trials. Dr. Karsh has authored a number of peer-reviewed publications and serves on the editorial boards for “Bladder Cancer.” He is an active member of the AUA, , ASCO, BCAN, SUO,SWOG and the Denver Academy of Surgeons. Dr. Karsh served on the board of SUO from 2010-2020 and served on the bladder cancer subcommittee during that time.
Ferring Pharmaceuticals, Inc.
Website for more information: ADSTILADRIN
#cancer #bladdercancer #drkarsh #mike
